APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tick-borne Encephalitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tick-borne Encephalitis Vaccine Industry Growth and Trends Forecast to 2032

Report ID 174041290120 December 202597 pages

Choose your research edition.

Industry ResearchTick-borne Encephalitis Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Tick-borne Encephalitis Vaccine Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Tick-borne Encephalitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tick-borne Encephalitis Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tick-borne Encephalitis Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Tick-borne Encephalitis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tick-borne Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tick-borne Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tick-borne Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tick-borne Encephalitis Vaccine include Pfizer, Superdrug Health, Sonic HealthPlus, Encephalitis and Cochrane Collaboration, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tick-borne Encephalitis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tick-borne Encephalitis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tick-borne Encephalitis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tick-borne Encephalitis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tick-borne Encephalitis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tick-borne Encephalitis Vaccine Market by Company

Pfizer

Superdrug Health

Sonic HealthPlus

Encephalitis

Cochrane Collaboration

Tick-borne Encephalitis Vaccine Segment by Type

European TBE Virus

Siberian TBE Virus

Far Eastern TBE Virus

Tick-borne Encephalitis Vaccine Segment by Application

Adult Vaccines

Pediatric Vaccines

Traveler Vaccines

Tick-borne Encephalitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tick-borne Encephalitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tick-borne Encephalitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tick-borne Encephalitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tick-borne Encephalitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tick-borne Encephalitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of European TBE Virus Table 2. Major Company of Siberian TBE Virus Table 3. Major Company of Far Eastern TBE Virus Table 4. Global Tick-borne Encephalitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 6. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Tick-borne Encephalitis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Tick-borne Encephalitis Vaccine Sales by Type (2027-2032) & (K Units) Table 11. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Tick-borne Encephalitis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Tick-borne Encephalitis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 16. North America Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 18. Europe Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Tick-borne Encephalitis Vaccine Industry Trends Table 26. Tick-borne Encephalitis Vaccine Industry Drivers Table 27. Tick-borne Encephalitis Vaccine Industry Opportunities and Challenges Table 28. Tick-borne Encephalitis Vaccine Industry Restraints Table 29. Global Tick-borne Encephalitis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Tick-borne Encephalitis Vaccine Sales by Company (2021-2026) & (K Units) Table 32. Global Tick-borne Encephalitis Vaccine Sales Share by Company (2021-2026) Table 33. Global Tick-borne Encephalitis Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Tick-borne Encephalitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Tick-borne Encephalitis Vaccine Major Company Production Sites and Headquarters Table 36. Global Tick-borne Encephalitis Vaccine Company, Product Type & Application Table 37. Global Tick-borne Encephalitis Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Tick-borne Encephalitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Tick-borne Encephalitis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Tick-borne Encephalitis Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Tick-borne Encephalitis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Tick-borne Encephalitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Tick-borne Encephalitis Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Tick-borne Encephalitis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Tick-borne Encephalitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Tick-borne Encephalitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Tick-borne Encephalitis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Tick-borne Encephalitis Vaccine Sales by Application (2027-2032) & (K Units) Table 58. Global Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Tick-borne Encephalitis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Tick-borne Encephalitis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 63. North America Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 65. Europe Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Tick-borne Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Pfizer Tick-borne Encephalitis Vaccine Product Portfolio Table 76. Pfizer Recent Development Table 77. Superdrug Health Company Information Table 78. Superdrug Health Business Overview Table 79. Superdrug Health Tick-borne Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Superdrug Health Tick-borne Encephalitis Vaccine Product Portfolio Table 81. Superdrug Health Recent Development Table 82. Sonic HealthPlus Company Information Table 83. Sonic HealthPlus Business Overview Table 84. Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Portfolio Table 86. Sonic HealthPlus Recent Development Table 87. Encephalitis Company Information Table 88. Encephalitis Business Overview Table 89. Encephalitis Tick-borne Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Encephalitis Tick-borne Encephalitis Vaccine Product Portfolio Table 91. Encephalitis Recent Development Table 92. Cochrane Collaboration Company Information Table 93. Cochrane Collaboration Business Overview Table 94. Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Portfolio Table 96. Cochrane Collaboration Recent Development Table 97. North America Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America Tick-borne Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 99. North America Tick-borne Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 100. North America Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 102. North America Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Tick-borne Encephalitis Vaccine Market Share by Country (2021-2026) Table 105. North America Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Tick-borne Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 107. Europe Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe Tick-borne Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 109. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 110. Europe Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Tick-borne Encephalitis Vaccine Market Share by Country (2021-2026) Table 115. Europe Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Tick-borne Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Tick-borne Encephalitis Vaccine Market Share by Country (2021-2026) Table 125. Asia-Pacific Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Tick-borne Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 127. Latin America Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America Tick-borne Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 129. Latin America Tick-borne Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 130. Latin America Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Tick-borne Encephalitis Vaccine Market Share by Country (2021-2026) Table 135. Latin America Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Tick-borne Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Tick-borne Encephalitis Vaccine Market Share by Country (2021-2026) Table 145. Middle East and Africa Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Tick-borne Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Tick-borne Encephalitis Vaccine Distributors List Table 150. Tick-borne Encephalitis Vaccine Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Tick-borne Encephalitis Vaccine Image Figure 2. Global Tick-borne Encephalitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tick-borne Encephalitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Tick-borne Encephalitis Vaccine Sales (2021-2032) & (K Units) Figure 5. European TBE Virus Image Figure 6. Global European TBE Virus Sales YoY Growth (2021-2032) & (K Units) Figure 7. Siberian TBE Virus Image Figure 8. Global Siberian TBE Virus Sales YoY Growth (2021-2032) & (K Units) Figure 9. Far Eastern TBE Virus Image Figure 10. Global Far Eastern TBE Virus Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Tick-borne Encephalitis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Tick-borne Encephalitis Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Tick-borne Encephalitis Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adult Vaccines Image Figure 26. Global Adult Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pediatric Vaccines Image Figure 28. Global Pediatric Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 29. Traveler Vaccines Image Figure 30. Global Traveler Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Tick-borne Encephalitis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Tick-borne Encephalitis Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Tick-borne Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Tick-borne Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Tick-borne Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tick-borne Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Tick-borne Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Tick-borne Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Tick-borne Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Tick-borne Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tick-borne Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Tick-borne Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Tick-borne Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Tick-borne Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Tick-borne Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Tick-borne Encephalitis Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Tick-borne Encephalitis Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • European TBE Virus
  • Siberian TBE Virus
  • Far Eastern TBE Virus
Applications
  • Adult Vaccines
  • Pediatric Vaccines
  • Traveler Vaccines
Companies covered
  • Pfizer
  • Superdrug Health
  • Sonic HealthPlus
  • Encephalitis
  • Cochrane Collaboration

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tick-borne Encephalitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tick-borne Encephalitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tick-borne Encephalitis Vaccine Market by Type
  6. 1.3.1 European TBE Virus
  7. 1.3.2 Siberian TBE Virus
  8. 1.3.3 Far Eastern TBE Virus
  9. 1.4 Global Tick-borne Encephalitis Vaccine Market Size by Type
  10. 1.4.1 Global Tick-borne Encephalitis Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Tick-borne Encephalitis Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Tick-borne Encephalitis Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Tick-borne Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Tick-borne Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Tick-borne Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Tick-borne Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Tick-borne Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tick-borne Encephalitis Vaccine Industry Trends
  2. 2.2 Tick-borne Encephalitis Vaccine Industry Drivers
  3. 2.3 Tick-borne Encephalitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Tick-borne Encephalitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tick-borne Encephalitis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Tick-borne Encephalitis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Tick-borne Encephalitis Vaccine Price (2021-2026)
  4. 3.4 Global Tick-borne Encephalitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tick-borne Encephalitis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Tick-borne Encephalitis Vaccine Company, Product Type & Application
  7. 3.7 Global Tick-borne Encephalitis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tick-borne Encephalitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tick-borne Encephalitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tick-borne Encephalitis Vaccine Tier 1, Tier 2, and Tier 3
4 Tick-borne Encephalitis Vaccine Regional Status and Outlook
  1. 4.1 Global Tick-borne Encephalitis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tick-borne Encephalitis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Tick-borne Encephalitis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tick-borne Encephalitis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tick-borne Encephalitis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tick-borne Encephalitis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Tick-borne Encephalitis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tick-borne Encephalitis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tick-borne Encephalitis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tick-borne Encephalitis Vaccine by Application
  1. 5.1 Tick-borne Encephalitis Vaccine Market by Application
  2. 5.1.1 Adult Vaccines
  3. 5.1.2 Pediatric Vaccines
  4. 5.1.3 Traveler Vaccines
  5. 5.2 Global Tick-borne Encephalitis Vaccine Market Size by Application
  6. 5.2.1 Global Tick-borne Encephalitis Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tick-borne Encephalitis Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tick-borne Encephalitis Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tick-borne Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tick-borne Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tick-borne Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tick-borne Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tick-borne Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Tick-borne Encephalitis Vaccine Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Superdrug Health
  8. 6.2.1 Superdrug Health Company Information
  9. 6.2.2 Superdrug Health Business Overview
  10. 6.2.3 Superdrug Health Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Superdrug Health Tick-borne Encephalitis Vaccine Product Portfolio
  12. 6.2.5 Superdrug Health Recent Developments
  13. 6.3 Sonic HealthPlus
  14. 6.3.1 Sonic HealthPlus Company Information
  15. 6.3.2 Sonic HealthPlus Business Overview
  16. 6.3.3 Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Portfolio
  18. 6.3.5 Sonic HealthPlus Recent Developments
  19. 6.4 Encephalitis
  20. 6.4.1 Encephalitis Company Information
  21. 6.4.2 Encephalitis Business Overview
  22. 6.4.3 Encephalitis Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Encephalitis Tick-borne Encephalitis Vaccine Product Portfolio
  24. 6.4.5 Encephalitis Recent Developments
  25. 6.5 Cochrane Collaboration
  26. 6.5.1 Cochrane Collaboration Company Information
  27. 6.5.2 Cochrane Collaboration Business Overview
  28. 6.5.3 Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Portfolio
  30. 6.5.5 Cochrane Collaboration Recent Developments
7 North America by Country
  1. 7.1 North America Tick-borne Encephalitis Vaccine Sales by Country
  2. 7.1.1 North America Tick-borne Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tick-borne Encephalitis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tick-borne Encephalitis Vaccine Market Size by Country
  6. 7.2.1 North America Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tick-borne Encephalitis Vaccine Sales by Country
  2. 8.1.1 Europe Tick-borne Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tick-borne Encephalitis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tick-borne Encephalitis Vaccine Market Size by Country
  6. 8.2.1 Europe Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Tick-borne Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tick-borne Encephalitis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tick-borne Encephalitis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tick-borne Encephalitis Vaccine Sales by Country
  2. 10.1.1 South America Tick-borne Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tick-borne Encephalitis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tick-borne Encephalitis Vaccine Market Size by Country
  6. 10.2.1 South America Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Tick-borne Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tick-borne Encephalitis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tick-borne Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tick-borne Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tick-borne Encephalitis Vaccine Value Chain Analysis
  2. 12.1.1 Tick-borne Encephalitis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tick-borne Encephalitis Vaccine Production Mode & Process
  7. 12.2 Tick-borne Encephalitis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tick-borne Encephalitis Vaccine Distributors
  10. 12.2.3 Tick-borne Encephalitis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst